» Articles » PMID: 30957737

Should We Start a Nationwide Screening Program for Critical Congenital Heart Disease in Turkey? A Pilot Study on Four Centres with Different Altitudes

Overview
Journal Cardiol Young
Date 2019 Apr 9
PMID 30957737
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To investigate the feasibility of critical congenital heart disease (CCHD) screening test by pulse oximetry in four geographical regions of Turkey with different altitudes, before implementation of a nationwide screening program.

Methods: It was a prospective multi-centre study performed in four centres, between December, 2015 and May, 2017. Pre- and post-ductal oxygen saturations and perfusion indices (PI) were measured using Masimo Radical-7 at early postnatal days. The results were evaluated according to the algorithm recommended by the American Academy of Pediatrics. Additionally, a PI value <0.7 was accepted to be significant.

Results: In 4888 newborns, the mean screening time was 31.5 ± 12.1 hours. At first attempt, the mean values of pre- and post-ductal measurements were: saturation 97.3 ± 1.8%, PI 2.8 ± 2.0, versus saturation 97.7 ± 1.8%, PI 2.3±1.3, respectively. Pre-ductal saturations and PI and post-ductal saturations were the lowest in Centre 4 with the highest altitude. Overall test positivity rate was 0.85% (n = 42). CCHD was detected in six babies (0.12%). Of them, right hand (91 ± 6.3) and foot saturations (92.1 ± 4.3%) were lower compared to ones with non-CCHD and normal variants (p <0.05, for all comparisons). Sensitivity, specificity, positive and negative predictive values, and likelihood ratio of the test were: 83.3%, 99.9%, 11.9%, 99.9%, and 99.2%, respectively.

Conclusion: This study concluded that pulse oximetry screening is an effective screening tool for congenital heart disease in newborns at different altitudes. We support the implementation of a national screening program with consideration of altitude differences for our country.

Citing Articles

Pulse oximetry test for screening congenital heart diseases: a systematic review.

Saganski G, Freire M, Santos W Rev Esc Enferm USP. 2024; 57:e20230215.

PMID: 38426937 PMC: 10906467. DOI: 10.1590/1980-220X-REEUSP-2023-0215en.


Investigation of infant deaths associated with critical congenital heart diseases; 2018-2021, Türkiye.

Caylan N, Yalcin S, Tezel B, Uner O, Aydin S, Kara F BMC Public Health. 2024; 24(1):441.

PMID: 38347475 PMC: 10860226. DOI: 10.1186/s12889-024-17966-4.


Neonatal Outcomes of Critical Congenital Heart Defects: A Multicenter Epidemiological Study of Turkish Neonatal Society : Neonatal Outcomes of CCHD.

Dilli D, Akduman H, Zenciroglu A, Cetinkaya M, Okur N, Turan O Pediatr Cardiol. 2023; 45(2):257-271.

PMID: 38153547 DOI: 10.1007/s00246-023-03362-z.


Evaluation of critical congenital heart disease from 2018 to 2020 in Turkey: a retrospective cohort study.

Caylan N, Yalcin S, Tezel B, Uner O, Aydin S, Kara F BMC Pregnancy Childbirth. 2023; 23(1):871.

PMID: 38104075 PMC: 10724899. DOI: 10.1186/s12884-023-06193-1.


Trajectories of oxygen saturation within 6-72 hours after birth in neonates at moderate altitude: a prospective longitudinal cohort study.

Zhao Q, Chen H, Li S, Yan W, Hu X, Huang G World J Pediatr. 2023; 19(9):894-901.

PMID: 36780108 PMC: 10423138. DOI: 10.1007/s12519-023-00687-w.